Levothyroxine Infusion Does Not Increase Heart Transplants Versus Saline Infusion
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 30, 2023 -- Intravenous levothyroxine infusion does not result in more hearts being transplanted than saline infusion among hemodynamically unstable brain-dead potential heart donors, according to a study published in the Nov. 30 issue of the New England Journal of Medicine.
Rajat Dhar, M.D., from the Washington University School of Medicine in St. Louis, and colleagues randomly assigned 838 hemodynamically unstable potential heart donors within 24 hours after declaration of death according to neurologic criteria to open-label infusion of intravenous levothyroxine or saline placebo (419 to each) in a trial involving 15 U.S. organ-procurement organizations.
Hearts were transplanted from 230 and 223 donors (54.9 and 53.2 percent) in the levothyroxine and saline groups, respectively (adjusted risk ratio, 1.01; 95 percent confidence interval, 0.97 to 1.07; P = 0.57). The researchers found that graft survival at 30 days occurred in 97.4 and 95.5 percent of hearts transplanted from donors assigned to receive levothyroxine and saline, respectively (difference, 1.9 percentage points; 95 percent confidence interval, −2.3 to 6.0; P < 0.001 for noninferiority). No substantial differences were seen between the groups in weaning from vasopressor therapy, ejection fraction on echocardiography, or organs transplanted per donor; there were more cases of severe hypertension and tachycardia in the levothyroxine versus the saline group.
"We found no significant benefit of intravenous levothyroxine treatment on improving donor heart utilization," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Heart Transplant Offer Acceptance Highest for White Women
TUESDAY, March 26, 2024 -- The cumulative incidence of heart transplant offer acceptance is highest for White women, according to a study published online March 25 in the Journal...
Metabolic, Bariatric Surgery Provides Pathway to Transplant in ESRD
TUESDAY, March 12, 2024 -- Referral of obese end-stage renal disease (ESRD) patients to metabolic and bariatric surgery (MBS) could offer a pathway to transplant, according to a...
No Improvement Noted in Black-White Kidney Transplant Rate Ratios
THURSDAY, Dec. 21, 2023 -- For patients with kidney failure, there appears to be no substantial improvement over time in the observed or adjusted Black-White mean living donor...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.